发明名称 HSP90 INHIBITORS WITH MODIFIED TOXICITY
摘要 The invention provides purified 19-substituted geldanamycin derivatives, pharmaceutically acceptable salts thereof and prodrugs thereof that are potent Hsp90 binding agents that are useful for the treatment and/or the amelioration of symptoms of cancer and other proliferative tissue disorders.
申请公布号 US2012022011(A1) 申请公布日期 2012.01.26
申请号 US20080673996 申请日期 2008.08.22
申请人 ROSS DAVID;SIEGEL DAVID;GUO WENCHANG;MOODY CHRISTOPHER J.;MCERLEAN CHRISTOPHER S.P.;THE REGENTS OF THE UNIVERSITY OF COLORADO 发明人 ROSS DAVID;SIEGEL DAVID;GUO WENCHANG;MOODY CHRISTOPHER J.;MCERLEAN CHRISTOPHER S.P.
分类号 A61K31/704;A61K31/337;A61K31/395;A61P35/00;C07D225/06 主分类号 A61K31/704
代理机构 代理人
主权项
地址